Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors  Nikolaos P. Polyzos, Dominic Stoop, Christophe.

Slides:



Advertisements
Similar presentations
Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis  Sesh Kamal Sunkara, Jyotsna Pundir,
Advertisements

Programmes and prospects for ovotechnology
Cancer and fertility: strategies to preserve fertility
Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C
Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase  TG Lainas, IA Sfontouris, IZ Zorzovilis, GK Petsas,
Fresh and cryopreserved ovary transplantation and resting follicle recruitment  Sherman Silber, Jorge Pineda, Kathleen Lenahan, Michael DeRosa, Jeffrey.
FMR1 gene CGG repeat variation within the normal range is not predictive of ovarian response in IVF cycles  Scott J. Morin, Ashley W. Tiegs, Jason M.
Double GnRH-antagonist dose before HCG administration may prevent OHSS in oocyte-donor cycles: a pilot study  Yannis Prapas, Ioannis Panagiotidis, Ioannis.
External validation of nomogram for the decline in serum anti-Müllerian hormone in women: a population study of 15,834 infertility patients  Scott M.
Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction  J.-C. Arce, A. Balen, P. Platteau, G. Pettersson,
E. Jauniaux, I. Ben-Ami, R. Maymon  Reproductive BioMedicine Online 
Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization–intracytoplasmic.
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction  Antonio La Marca, Giovanni D’Ippolito 
Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol  Qi Yao, Yuanjiao Liang, Yong.
E. Jauniaux, I. Ben-Ami, R. Maymon  Reproductive BioMedicine Online 
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH  George Griesinger, Daniel B. Shapiro, Efstratios.
Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial  Christophe Blockeel, Sara Engels, Michel De Vos, Patrick Haentjens,
A. La Marca, G. Sighinolfi, S. Giulini, M. Traglia, C. Argento, C
In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation 
L. L. van Loendersloot, M. van Wely, S. Repping, F. van der Veen, P. M
Ovarian response to 150 µg corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study  Tamara Lerman, Marion Depenbusch,
Follicular-fluid anti-Mullerian hormone concentrations are predictive of assisted reproduction outcome in PCOS patients  Recai Pabuccu, Cemil Kaya, Gamze.
Anti-Müllerian hormone as a predictor of pregnancy following IVF
Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles  Reshef Tal, David B. Seifer, Moisey Khanimov, Eliana.
Sherman Silber  Reproductive BioMedicine Online 
Why are reproductive cancers more common in nulliparous women?
Hillary B. Alberta, Roberta M. Berry, Aaron D. Levine 
Utility of age-specific serum anti-Müllerian hormone concentrations
S Munné, E Fragouli, P Colls, MG Katz-Jaffe, WB Schoolcraft, D Wells 
Sarah McCredie, William Ledger, Christos A. Venetis 
Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study  A. Nasr  Reproductive BioMedicine Online 
Effect of energy expenditure and physical activity on the outcomes of assisted reproduction treatment  Mert Kucuk, Fadime Doymaz, Bulent Urman  Reproductive.
M. Dieterich, M. Bolz, T. Reimer, S. Costagliola, B. Gerber 
Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype  C. Dechanet, C. Castelli,
Ronit Machtinger, Raoul Orvieto  Reproductive BioMedicine Online 
Male age negatively influences clinical pregnancy rate in women younger than 40 years undergoing donor insemination cycles  Su-Ann Koh, Katherine Sanders,
Donor information considered important to donors, recipients and offspring: an Australian perspective  I.S. Rodino, P.J. Burton, K.A. Sanders  Reproductive.
Dehydroepiandrostendione sulphate and prediction of live birth after IVF in young women with low anti-Müllerian hormone concentration  Miro Šimun Alebić,
A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor  X.J. Sun, L. Jiang, L.C. Ji, R. Nie,
Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors  Alberta Maria Fabris, Maria Cruz, Carlos Iglesias,
Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial  Juan Antonio García-Velasco, Sanja.
Cumulative delivery rates after ICSI with donor spermatozoa in different age groups  Michaël De Brucker, Michel Camus, Patrick Haentjens, Jacques Francotte,
Intra-cycle variation of the uterine cavity indentation assessed with three-dimensional ultrasound in natural and stimulated cycles  Sotirios H. Saravelos,
Double GnRH-antagonist dose before HCG administration may prevent OHSS in oocyte-donor cycles: a pilot study  Yannis Prapas, Ioannis Panagiotidis, Ioannis.
LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles  Kevin Doody, Paul Devroey, Keith Gordon, Han Witjes, Bernadette Mannaerts 
Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management – meta-analyses  Daniele Santi, Giorgia.
Does ovarian stimulation regimen affect IVF outcome
Follicle recruitment determines IVF productivity rate via the number of embryos frozen and subsequent transfers  James D. Stanger, John L. Yovich  Reproductive.
Should we be promoting embryo transfer at blastocyst stage?
Stephen C. Collins, Esther Chan  Reproductive BioMedicine Online 
Predicting pregnancy rate following multiple embryo transfers using algorithms developed through static image analysis  Yun Tian, Wei Wang, Yabo Yin,
GnRH antagonist pre-treatment: one centre's experience for IVF–ICSI cycle scheduling  Veronique Viardot-Foucault, Sadhana Nadarajah, Weng Kit Lye, Heng.
Pietro Gambadauro, Ramesan Navaratnarajah 
Genome-wide analysis shows no genomic predictors of ovarian response to stimulation by exogenous FSH for IVF  Jeroen van Disseldorp, Lude Franke, Rene.
The Alpha Consensus Meeting on the professional status of the clinical embryologist: proceedings of an expert meeting    Reproductive BioMedicine Online 
A. La Marca, S. M. Nelson, G. Sighinolfi, M. Manno, E. Baraldi, L
Nigel Pereira, Anna Voskuilen-Gonzalez, Kolbe Hancock, Jovana P
Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF  Thomas Freour, Lionel Dessolle, Miguel Jean, Damien Masson,
Ovarian reserve screening before contraception?
Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH  Basil C. Tarlatzis,
The significance of the number of CGG repeats and autoantibodies in premature ovarian failure  Cem Fıçıcıoglu, Gazi Yildirim, Rukset Attar, Banu Kumbak,
Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study  E.G. Papanikolaou, C. Bourgain, H. Fatemi,
Final oocyte maturation with two different GnRH agonists in antagonist co-treated cycles at risk of ovarian hyperstimulation syndrome  Yavuz Emre Şükür,
Programmes and prospects for ovotechnology
Claudio Manna, Loris Nanni, Alessandra Lumini, Sebastiana Pappalardo 
Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone.
John Yovich, James Stanger, Peter Hinchliffe 
First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for.
M. Franz, J. Ott, A. Watrelot, L. Küssel, H. Husslein 
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive.
Presentation transcript:

Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors  Nikolaos P. Polyzos, Dominic Stoop, Christophe Blockeel, Paul Adriaensen, Peter Platteau, Ellen Anckaert, Johan Smitz, Paul Devroey  Reproductive BioMedicine Online  Volume 24, Issue 5, Pages 532-539 (May 2012) DOI: 10.1016/j.rbmo.2012.01.024 Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Receiver operating characteristic curves for anti-Müllerian hormone, age and basal FSH for the prediction of low response (⩽6 oocytes) and excessive response (>20 oocytes). Reproductive BioMedicine Online 2012 24, 532-539DOI: (10.1016/j.rbmo.2012.01.024) Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions

Figure 2 Scatterplot for the distribution of anti-Müllerian hormone values according to the level of ovarian response (low, normal and excessive response). Reproductive BioMedicine Online 2012 24, 532-539DOI: (10.1016/j.rbmo.2012.01.024) Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.